JOHNSON & JOHNSON — JNJ

CIK

0000200406

Tickers

JNJ

Exchange

NYSE

SIC

2834 Pharmaceutical Preparations

Status

ok

{"freshness":{"dto_schema_version":"meridian-agent-site/v1","status":"ok","status_reason":"ok","tearsheet_asof":"2026-07-16","tearsheet_schema_version":"financial-tearsheets/v1"},"identity":{"aliases":["JNJ"],"canonical_ticker":"JNJ","cik":"0000200406","exchange":"NYSE","industry_key":"healthcare","name":"JOHNSON & JOHNSON","sic":"2834","sic_description":"Pharmaceutical Preparations"},"shares":{"as_of":"2026-07-08","float_shares":2402224450,"free_float_factor":0.997926,"total_shares":2407216971}}

fundamentals[115]{fiscal_year,end,metric,value,unit,currency,filing_date,form,accession,concept}:
  2025,2025-12-28,revenue,94193000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
  2025,2025-12-28,cost_of_revenue,30256000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:CostOfGoodsAndServicesSold"
  2025,2025-12-28,gross_profit,63937000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:GrossProfit"
  2025,2025-12-28,selling_general_and_administrative,23676000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:SellingGeneralAndAdministrativeExpense"
  2025,2025-12-28,research_and_development,109000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:ResearchAndDevelopmentExpense"
  2025,2025-12-28,interest_expense,971000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:InterestExpenseNonoperating"
  2025,2025-12-28,pretax_income,32581000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"
  2025,2025-12-28,income_tax_expense,5777000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:IncomeTaxExpenseBenefit"
  2025,2025-12-28,net_income,26804000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:NetIncomeLoss"
  2025,2025-12-28,cash_and_equivalents,19709000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:CashAndCashEquivalentsAtCarryingValue"
  2025,2025-12-28,current_assets,55624000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:AssetsCurrent"
  2025,2025-12-28,total_assets,199210000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:Assets"
  2025,2025-12-28,current_liabilities,54126000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:LiabilitiesCurrent"
  2025,2025-12-28,total_liabilities,117666000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:Liabilities"
  2025,2025-12-28,stockholders_equity,81544000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"
  2025,2025-12-28,operating_cash_flow,24530000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:NetCashProvidedByUsedInOperatingActivities"
  2025,2025-12-28,depreciation_and_amortization,7503000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:DepreciationDepletionAndAmortization"
  2025,2025-12-28,stock_based_compensation,1354000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:ShareBasedCompensation"
  2025,2025-12-28,capex,4832000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:PaymentsToAcquirePropertyPlantAndEquipment"
  2025,2025-12-28,free_cash_flow,19698000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"derived:operating_cash_flow-minus-capex"
  2025,2025-12-28,dividends_paid,12381000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:PaymentsOfOrdinaryDividends"
  2025,2025-12-28,share_repurchases,5953000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:PaymentsForRepurchaseOfCommonStock"
  2025,2025-12-28,impairments,204000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:AssetImpairmentCharges"
  2025,2024-12-29,revenue,88821000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
  2025,2024-12-29,cost_of_revenue,27471000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:CostOfGoodsAndServicesSold"
  2025,2024-12-29,gross_profit,61350000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:GrossProfit"
  2025,2024-12-29,selling_general_and_administrative,22869000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:SellingGeneralAndAdministrativeExpense"
  2025,2024-12-29,research_and_development,1841000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:ResearchAndDevelopmentExpense"
  2025,2024-12-29,interest_expense,755000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:InterestExpenseNonoperating"
  2025,2024-12-29,pretax_income,16687000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"
  2025,2024-12-29,income_tax_expense,2621000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:IncomeTaxExpenseBenefit"
  2025,2024-12-29,net_income,14066000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:NetIncomeLoss"
  2025,2024-12-29,cash_and_equivalents,24105000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:CashAndCashEquivalentsAtCarryingValue"
  2025,2024-12-29,current_assets,55893000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:AssetsCurrent"
  2025,2024-12-29,total_assets,180104000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:Assets"
  2025,2024-12-29,current_liabilities,50321000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:LiabilitiesCurrent"
  2025,2024-12-29,total_liabilities,108614000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:Liabilities"
  2025,2024-12-29,stockholders_equity,71490000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"
  2025,2024-12-29,operating_cash_flow,24266000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:NetCashProvidedByUsedInOperatingActivities"
  2025,2024-12-29,depreciation_and_amortization,7339000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:DepreciationDepletionAndAmortization"
  2025,2024-12-29,stock_based_compensation,1176000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:ShareBasedCompensation"
  2025,2024-12-29,capex,4424000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:PaymentsToAcquirePropertyPlantAndEquipment"
  2025,2024-12-29,free_cash_flow,19842000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"derived:operating_cash_flow-minus-capex"
  2025,2024-12-29,dividends_paid,11823000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:PaymentsOfOrdinaryDividends"
  2025,2024-12-29,share_repurchases,2432000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:PaymentsForRepurchaseOfCommonStock"
  2025,2024-12-29,impairments,405000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:AssetImpairmentCharges"
  2025,2023-12-31,revenue,85159000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
  2025,2023-12-31,cost_of_revenue,26553000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:CostOfGoodsAndServicesSold"
  2025,2023-12-31,gross_profit,58606000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:GrossProfit"
  2025,2023-12-31,selling_general_and_administrative,21512000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:SellingGeneralAndAdministrativeExpense"
  2025,2023-12-31,research_and_development,483000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:ResearchAndDevelopmentExpense"
  2025,2023-12-31,interest_expense,772000000.0,USD,USD,2024-02-16,10-K,0000200406-24-000013,"us-gaap:InterestExpense"
  2025,2023-12-31,pretax_income,15062000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"
  2025,2023-12-31,income_tax_expense,1736000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:IncomeTaxExpenseBenefit"
  2025,2023-12-31,net_income,35153000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:NetIncomeLoss"
  2025,2023-12-31,cash_and_equivalents,21859000000.0,USD,USD,2025-02-13,10-K,0000200406-25-000038,"us-gaap:CashAndCashEquivalentsAtCarryingValue"
  2025,2023-12-31,current_assets,53495000000.0,USD,USD,2025-02-13,10-K,0000200406-25-000038,"us-gaap:AssetsCurrent"
  2025,2023-12-31,total_assets,167558000000.0,USD,USD,2025-02-13,10-K,0000200406-25-000038,"us-gaap:Assets"
  2025,2023-12-31,current_liabilities,46282000000.0,USD,USD,2025-02-13,10-K,0000200406-25-000038,"us-gaap:LiabilitiesCurrent"
  2025,2023-12-31,total_liabilities,98784000000.0,USD,USD,2025-02-13,10-K,0000200406-25-000038,"us-gaap:Liabilities"
  2025,2023-12-31,stockholders_equity,68774000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"
  2025,2023-12-31,operating_cash_flow,22791000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:NetCashProvidedByUsedInOperatingActivities"
  2025,2023-12-31,depreciation_and_amortization,7486000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:DepreciationDepletionAndAmortization"
  2025,2023-12-31,stock_based_compensation,1162000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:ShareBasedCompensation"
  2025,2023-12-31,capex,4543000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:PaymentsToAcquirePropertyPlantAndEquipment"
  2025,2023-12-31,free_cash_flow,18248000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"derived:operating_cash_flow-minus-capex"
  2025,2023-12-31,dividends_paid,11770000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:PaymentsOfOrdinaryDividends"
  2025,2023-12-31,share_repurchases,5054000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:PaymentsForRepurchaseOfCommonStock"
  2025,2023-12-31,impairments,1295000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:AssetImpairmentCharges"
  2024,2023-01-01,revenue,79990000000.0,USD,USD,2025-02-13,10-K,0000200406-25-000038,"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
  2024,2023-01-01,cost_of_revenue,24596000000.0,USD,USD,2025-02-13,10-K,0000200406-25-000038,"us-gaap:CostOfGoodsAndServicesSold"
  2024,2023-01-01,gross_profit,55394000000.0,USD,USD,2025-02-13,10-K,0000200406-25-000038,"us-gaap:GrossProfit"
  2024,2023-01-01,selling_general_and_administrative,20246000000.0,USD,USD,2025-02-13,10-K,0000200406-25-000038,"us-gaap:SellingGeneralAndAdministrativeExpense"
  2024,2023-01-01,research_and_development,0.0,USD,USD,2025-02-13,10-K,0000200406-25-000038,"us-gaap:ResearchAndDevelopmentExpense"
  2024,2023-01-01,interest_expense,276000000.0,USD,USD,2024-02-16,10-K,0000200406-24-000013,"us-gaap:InterestExpense"
  2024,2023-01-01,pretax_income,19359000000.0,USD,USD,2025-02-13,10-K,0000200406-25-000038,"us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"
  2024,2023-01-01,income_tax_expense,2989000000.0,USD,USD,2025-02-13,10-K,0000200406-25-000038,"us-gaap:IncomeTaxExpenseBenefit"
  2024,2023-01-01,net_income,17941000000.0,USD,USD,2025-02-13,10-K,0000200406-25-000038,"us-gaap:NetIncomeLoss"
  2024,2023-01-01,cash_and_equivalents,12889000000.0,USD,USD,2024-02-16,10-K,0000200406-24-000013,"us-gaap:CashAndCashEquivalentsAtCarryingValue"
  2024,2023-01-01,current_assets,55294000000.0,USD,USD,2024-02-16,10-K,0000200406-24-000013,"us-gaap:AssetsCurrent"
  2024,2023-01-01,total_assets,187378000000.0,USD,USD,2024-02-16,10-K,0000200406-24-000013,"us-gaap:Assets"
  2024,2023-01-01,current_liabilities,55802000000.0,USD,USD,2024-02-16,10-K,0000200406-24-000013,"us-gaap:LiabilitiesCurrent"
  2024,2023-01-01,total_liabilities,110574000000.0,USD,USD,2024-02-16,10-K,0000200406-24-000013,"us-gaap:Liabilities"
  2024,2023-01-01,stockholders_equity,76804000000.0,USD,USD,2026-02-11,10-K,0000200406-26-000016,"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"
  2024,2023-01-01,operating_cash_flow,21194000000.0,USD,USD,2025-02-13,10-K,0000200406-25-000038,"us-gaap:NetCashProvidedByUsedInOperatingActivities"
  2024,2023-01-01,depreciation_and_amortization,6970000000.0,USD,USD,2025-02-13,10-K,0000200406-25-000038,"us-gaap:DepreciationDepletionAndAmortization"
  2024,2023-01-01,stock_based_compensation,1138000000.0,USD,USD,2025-02-13,10-K,0000200406-25-000038,"us-gaap:ShareBasedCompensation"
  2024,2023-01-01,capex,4009000000.0,USD,USD,2025-02-13,10-K,0000200406-25-000038,"us-gaap:PaymentsToAcquirePropertyPlantAndEquipment"
  2024,2023-01-01,free_cash_flow,17185000000.0,USD,USD,2025-02-13,10-K,0000200406-25-000038,"derived:operating_cash_flow-minus-capex"
  2024,2023-01-01,dividends_paid,11682000000.0,USD,USD,2025-02-13,10-K,0000200406-25-000038,"us-gaap:PaymentsOfOrdinaryDividends"
  2024,2023-01-01,share_repurchases,6035000000.0,USD,USD,2025-02-13,10-K,0000200406-25-000038,"us-gaap:PaymentsForRepurchaseOfCommonStock"
  2024,2023-01-01,impairments,1216000000.0,USD,USD,2025-02-13,10-K,0000200406-25-000038,"us-gaap:AssetImpairmentCharges"
  2023,2022-01-02,revenue,78740000000.0,USD,USD,2024-02-16,10-K,0000200406-24-000013,"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax"
  2023,2022-01-02,cost_of_revenue,23402000000.0,USD,USD,2024-02-16,10-K,0000200406-24-000013,"us-gaap:CostOfGoodsAndServicesSold"
  2023,2022-01-02,gross_profit,55338000000.0,USD,USD,2024-02-16,10-K,0000200406-24-000013,"us-gaap:GrossProfit"
  2023,2022-01-02,selling_general_and_administrative,20118000000.0,USD,USD,2024-02-16,10-K,0000200406-24-000013,"us-gaap:SellingGeneralAndAdministrativeExpense"
  2023,2022-01-02,research_and_development,0.0,USD,USD,2024-02-16,10-K,0000200406-24-000013,"us-gaap:ResearchAndDevelopmentExpense"
  2023,2022-01-02,interest_expense,183000000.0,USD,USD,2024-02-16,10-K,0000200406-24-000013,"us-gaap:InterestExpense"
  2023,2022-01-02,pretax_income,19178000000.0,USD,USD,2024-02-16,10-K,0000200406-24-000013,"us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"
  2023,2022-01-02,income_tax_expense,1377000000.0,USD,USD,2024-02-16,10-K,0000200406-24-000013,"us-gaap:IncomeTaxExpenseBenefit"
  2023,2022-01-02,net_income,20878000000.0,USD,USD,2024-02-16,10-K,0000200406-24-000013,"us-gaap:NetIncomeLoss"
  2023,2022-01-02,cash_and_equivalents,14487000000.0,USD,USD,2023-02-16,10-K,0000200406-23-000016,"us-gaap:CashAndCashEquivalentsAtCarryingValue"
  2023,2022-01-02,current_assets,60979000000.0,USD,USD,2023-02-16,10-K,0000200406-23-000016,"us-gaap:AssetsCurrent"
  2023,2022-01-02,total_assets,182018000000.0,USD,USD,2023-02-16,10-K,0000200406-23-000016,"us-gaap:Assets"
  2023,2022-01-02,current_liabilities,45226000000.0,USD,USD,2023-02-16,10-K,0000200406-23-000016,"us-gaap:LiabilitiesCurrent"
  2023,2022-01-02,total_liabilities,107995000000.0,USD,USD,2023-02-16,10-K,0000200406-23-000016,"us-gaap:Liabilities"
  2023,2022-01-02,stockholders_equity,74023000000.0,USD,USD,2025-02-13,10-K,0000200406-25-000038,"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"
  2023,2022-01-02,operating_cash_flow,23410000000.0,USD,USD,2024-02-16,10-K,0000200406-24-000013,"us-gaap:NetCashProvidedByUsedInOperatingActivities"
  2023,2022-01-02,depreciation_and_amortization,7390000000.0,USD,USD,2024-02-16,10-K,0000200406-24-000013,"us-gaap:DepreciationDepletionAndAmortization"
  2023,2022-01-02,stock_based_compensation,1135000000.0,USD,USD,2024-02-16,10-K,0000200406-24-000013,"us-gaap:ShareBasedCompensation"
  2023,2022-01-02,capex,3652000000.0,USD,USD,2024-02-16,10-K,0000200406-24-000013,"us-gaap:PaymentsToAcquirePropertyPlantAndEquipment"
  2023,2022-01-02,free_cash_flow,19758000000.0,USD,USD,2024-02-16,10-K,0000200406-24-000013,"derived:operating_cash_flow-minus-capex"
  2023,2022-01-02,dividends_paid,11032000000.0,USD,USD,2024-02-16,10-K,0000200406-24-000013,"us-gaap:PaymentsOfOrdinaryDividends"
  2023,2022-01-02,share_repurchases,3456000000.0,USD,USD,2024-02-16,10-K,0000200406-24-000013,"us-gaap:PaymentsForRepurchaseOfCommonStock"
  2023,2022-01-02,impairments,989000000.0,USD,USD,2024-02-16,10-K,0000200406-24-000013,"us-gaap:AssetImpairmentCharges"

articles[2]{date,title,url,series,section,human_url}:
  2026-07-16,Johnson & Johnson Raises Outlook as Adjusted Earnings Rebound,"https://agents.meridianindices.com/articles/2026-07-16/earnings-jnj-johnson-johnson-raises-outlook-as-adjusted-earnings-rebound/",Earnings,earnings,"https://marketbrain.meridianindices.com/marketbrain-2026-07-16-earnings-jnj-johnson-johnson-raises-outlook-as-adjusted-earnings-rebound.html"
  2026-04-14,Johnson & Johnson Raises Outlook as Sales Accelerate,"https://agents.meridianindices.com/articles/2026-04-14/earnings-jnj-johnson-johnson-raises-outlook-as-sales-accelerate/",Earnings,earnings,"https://marketbrain.meridianindices.com/marketbrain-2026-04-14-earnings-jnj-johnson-johnson-raises-outlook-as-sales-accelerate.html"